Susanna Naggie, M.D.
Dr. Naggie is an infectious diseases (ID) specialist and associate professor of medicine at Duke University Medical Center. Her primary research interest is the care of patients with HIV and liver disease.
Naggie completed her medical education at Johns Hopkins University School of Medicine and her internal medicine training at Duke University Medical Center (DUMC), where she also served as a Chief Resident in Internal Medicine. She completed her Infectious Diseases (ID) fellowship training at Duke and then joined the faculty in the Division of ID. She is an Associate Professor of Medicine and currently holds appointments at DUMC (Director of Clinical Research Unit for Department of Medicine), the Duke Clinical Research Institute (Director of ID Research), and the Durham Veterans Affairs Medical Center. She is a K23 awardee and has transitioned to research independence with a translational research program in HIV and liver fibrogenesis and biomarker discovery. She has served as both site and national PI for clinical trials in infectious diseases including HIV, viral hepatitis, and fungal diseases. Naggie served as a member and co-Chair of the AASLD/IDSA HCV Guidance Committee for four years and is currently a member of the DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline Committee. She is the co-Chair of the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee which focuses on clinical trials in HIV and liver disease including HCV, HBV, and NAFLD/NASH.